Approval · Notice of Compliance 33693 · 2024
ALKERAN: Notice of Compliance 33693
Issued July 23, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33693
- Date
- July 23, 2024
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information. Update to Patient Medication Information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALKERAN | Not yet assigned | — |
Medicinal ingredients
- MELPHALAN 2 MG per TAB
- BUFFER SOLUTION 10 ML per VIAL
- MELPHALAN HCL 50 MG per VIAL